Literature DB >> 22345448

Paucity of HIV DNA methylation in latently infected, resting CD4+ T cells from infected individuals receiving antiretroviral therapy.

Jana Blazkova1, Danielle Murray, J Shawn Justement, Emily K Funk, Amy K Nelson, Susan Moir, Tae-Wook Chun, Anthony S Fauci.   

Abstract

Maintenance of HIV latency in vitro has been linked to methylation of HIV DNA. However, examinations of the degree of methylation of HIV DNA in the latently infected, resting CD4(+) T cells of infected individuals receiving antiretroviral therapy have been limited. Here, we show that methylation of the HIV 5' long terminal repeat (LTR) in the latent viral reservoir of HIV-infected aviremic individuals receiving therapy is rare, suggesting that other mechanisms are likely involved in the persistence of viral latency.

Entities:  

Mesh:

Year:  2012        PMID: 22345448      PMCID: PMC3347337          DOI: 10.1128/JVI.00040-12

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  13 in total

1.  Relationship between residual plasma viremia and the size of HIV proviral DNA reservoirs in infected individuals receiving effective antiretroviral therapy.

Authors:  Tae-Wook Chun; Danielle Murray; J Shawn Justement; Claire W Hallahan; Susan Moir; Colin Kovacs; Anthony S Fauci
Journal:  J Infect Dis       Date:  2011-07-01       Impact factor: 5.226

Review 2.  In vivo, in vitro, and in silico analysis of methylation of the HIV-1 provirus.

Authors:  Leonard Chávez; Steven Kauder; Eric Verdin
Journal:  Methods       Date:  2010-06-02       Impact factor: 3.608

3.  CpG island protects Rous sarcoma virus-derived vectors integrated into nonpermissive cells from DNA methylation and transcriptional suppression.

Authors:  J Hejnar; P Hájková; J Plachy; D Elleder; V Stepanets; J Svoboda
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-16       Impact factor: 11.205

4.  Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy.

Authors:  T W Chun; L Stuyver; S B Mizell; L A Ehler; J A Mican; M Baseler; A L Lloyd; M A Nowak; A S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-25       Impact factor: 11.205

5.  Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy.

Authors:  D Finzi; M Hermankova; T Pierson; L M Carruth; C Buck; R E Chaisson; T C Quinn; K Chadwick; J Margolick; R Brookmeyer; J Gallant; M Markowitz; D D Ho; D D Richman; R F Siliciano
Journal:  Science       Date:  1997-11-14       Impact factor: 47.728

6.  The survival benefits of AIDS treatment in the United States.

Authors:  Rochelle P Walensky; A David Paltiel; Elena Losina; Lauren M Mercincavage; Bruce R Schackman; Paul E Sax; Milton C Weinstein; Kenneth A Freedberg
Journal:  J Infect Dis       Date:  2006-06-01       Impact factor: 5.226

7.  Consistent, persistent expression from modified retroviral vectors in murine hematopoietic stem cells.

Authors:  P B Robbins; D C Skelton; X J Yu; S Halene; E H Leonard; D B Kohn
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-18       Impact factor: 11.205

8.  Recovery of replication-competent HIV despite prolonged suppression of plasma viremia.

Authors:  J K Wong; M Hezareh; H F Günthard; D V Havlir; C C Ignacio; C A Spina; D D Richman
Journal:  Science       Date:  1997-11-14       Impact factor: 47.728

9.  5'-long terminal repeat-selective CpG methylation of latent human T-cell leukemia virus type 1 provirus in vitro and in vivo.

Authors:  Tsukasa Koiwa; Akiko Hamano-Usami; Takaomi Ishida; Akihiko Okayama; Kazunari Yamaguchi; Shimeru Kamihira; Toshiki Watanabe
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

10.  CpG methylation controls reactivation of HIV from latency.

Authors:  Jana Blazkova; Katerina Trejbalova; Françoise Gondois-Rey; Philippe Halfon; Patrick Philibert; Allan Guiguen; Eric Verdin; Daniel Olive; Carine Van Lint; Jiri Hejnar; Ivan Hirsch
Journal:  PLoS Pathog       Date:  2009-08-21       Impact factor: 6.823

View more
  54 in total

Review 1.  HIV-1 transcription and latency: an update.

Authors:  Carine Van Lint; Sophie Bouchat; Alessandro Marcello
Journal:  Retrovirology       Date:  2013-06-26       Impact factor: 4.602

2.  H3K27 Demethylation at the Proviral Promoter Sensitizes Latent HIV to the Effects of Vorinostat in Ex Vivo Cultures of Resting CD4+ T Cells.

Authors:  Manoj K Tripathy; Mary E M McManamy; Brandon D Burch; Nancie M Archin; David M Margolis
Journal:  J Virol       Date:  2015-06-03       Impact factor: 5.103

Review 3.  Current Strategies for Elimination of HIV-1 Latent Reservoirs Using Chemical Compounds Targeting Host and Viral Factors.

Authors:  Maxime J Jean; Guillaume Fiches; Tsuyoshi Hayashi; Jian Zhu
Journal:  AIDS Res Hum Retroviruses       Date:  2018-12-12       Impact factor: 2.205

Review 4.  Barriers for HIV Cure: The Latent Reservoir.

Authors:  Sergio Castro-Gonzalez; Marta Colomer-Lluch; Ruth Serra-Moreno
Journal:  AIDS Res Hum Retroviruses       Date:  2018-08-28       Impact factor: 2.205

Review 5.  Transcriptional control of HIV latency: cellular signaling pathways, epigenetics, happenstance and the hope for a cure.

Authors:  Uri Mbonye; Jonathan Karn
Journal:  Virology       Date:  2014-02-22       Impact factor: 3.616

Review 6.  Host Methyltransferases and Demethylases: Potential New Epigenetic Targets for HIV Cure Strategies and Beyond.

Authors:  Daniela Boehm; Melanie Ott
Journal:  AIDS Res Hum Retroviruses       Date:  2017-11       Impact factor: 2.205

7.  Epigenetic analysis of HIV-1 proviral genomes from infected individuals: predominance of unmethylated CpG's.

Authors:  Stefanie Weber; Barbara Weiser; Kimdar S Kemal; Harold Burger; Christina M Ramirez; Klaus Korn; Kathryn Anastos; Rupert Kaul; Colin Kovacs; Walter Doerfler
Journal:  Virology       Date:  2013-12-05       Impact factor: 3.616

Review 8.  Current views on HIV-1 latency, persistence, and cure.

Authors:  Zora Melkova; Prakash Shankaran; Michaela Madlenakova; Josef Bodor
Journal:  Folia Microbiol (Praha)       Date:  2016-10-05       Impact factor: 2.099

Review 9.  Targeting HIV latency: resting memory T cells, hematopoietic progenitor cells and future directions.

Authors:  Nadia T Sebastian; Kathleen L Collins
Journal:  Expert Rev Anti Infect Ther       Date:  2014-09-04       Impact factor: 5.091

Review 10.  Combined approaches for HIV cure.

Authors:  David M Margolis; Daria J Hazuda
Journal:  Curr Opin HIV AIDS       Date:  2013-05       Impact factor: 4.283

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.